Expression Profiling and Subtype-Specific Expression of Stomach Cancer

Cancer Research

Volumn 63, Issue 23, 2003, Pages 8248-8255

  Kim, Byungsik ^a   Bang, Seunghyun ^a   Lee, Seungkoo ^a   Kim, Soonok ^a,c   Jung, Yusun ^a   Lee, Changhee ^a   Choi, Kyungho ^a   Lee, Seong Gene ^a   Lee, Kiwhan ^b   Lee, Yongsung ^b   Kim, Sang Soo ^d   Yeom, Yeong Il ^c   Kim, Yong Sung ^c   Yoo, Hyang Sook ^c   Song, Kyuyoung ^a   Lee, Inchul ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Hanyang University   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; TISSUE DISTRIBUTION; UNINDEXED SEQUENCE;

ADULT; AGED; CLUSTER ANALYSIS; FEMALE; GASTRIC MUCOSA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; STOMACH NEOPLASMS;

EID: 10744229353     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Neugut, A. I., Hayek, M., and Howe, G. Epidemiology of gastric cancer. Semin. Oncol., 23: 281-291, 1996.
2. Wemer, M., Becker, K. F., Keller, G., and Hofler, H. Gastric adenocarcinoma: pathomorphology and molecular pathology. J. Cancer Res. Clin. Oncol., 127: 207-216, 2001.
3. Correa, P. Helicobacter pylori as a pathogen and carcinogen. J. Physiol. Pharmacol., 48 (Suppl. 4): 19-24, 1997.
4. El-Rifai, W., Frierson, H. F., Harper, J. C., Powell, S. M., and Knuutila, S. Expression profiling of gastric adenocarcinoma using cDNA array. Int. J. Cancer, 92: 832-838, 2001.
5. Hippo, Y., Taniguchi, H., Tsutsumi. S., Machida, N., Chong, J-M., Fukayama, M., Kodama, T., and Aburatani, H. Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res., 62: 233-240, 2002.
6. Liu, L. X., Liu, Z. H., Jiang, H. C., Qu, X., Zhang, W. H., Wu, L. F., Zhu, A. L., Wang, X. Q., and Wu, M. Profiling of differentially expressed genes in human gastric carcinoma by cDNA expression array. World J. Gastroenterol., 8: 580-585, 2002.
7. Hippo, Y., Yashiro, M., Ishii, M., Taniguchi, H., Tsutsumi, S., Hirakawa, K., Kodama, T., and Aburatani, H. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res., 61: 889-895, 2001.
8. Nomura, H., Nishimori, H., Yasoshima, T., Hata, F., Sogahata, K., Tanaka, H., Nakajima, F., Ikeda, S., Kamiguchi, K., Isomura, H., Sato, N., Denno, R., and Hirata, K. A novel experimental mouse model of peritoneal dissemination of human gastric cancer cells: analysis of the mechanism of peritoneal dissemination using cDNA macroarrays. Jpn. J. Cancer Res., 92: 748-754, 2001,
9. Mori, M., Mimori, K., Yoshikawa, Y., Shibuta, K., Utsunomiya, T., Sadanaga, N., Tanaka, F., Matsuyama, A., Inoue, H., and Sugimachi, K. Analysis of the gene-expression profile regarding the progression of human gastric carcinoma. Surgery (St. Louis), 131: S39-S47, 2002.
10. Sakakura, C., Hagiwara, A., Nakanishi, M., Shimomura, K., Takagi, T., Yasuoka, R., Fujita, Y., Abe, T., Ichikawa, Y., Takahashi, S., Ishikawa, T., Nishizuka, I., Morita, T., Shimada, H., Okazaki, Y., Hayashizaki, Y., and Yamagishi, H. Differential gene expression profiles of gastric cancer cells established from primary tumour and malignant ascites. Br. J. Cancer, 87: 1153-1161, 2002.
11. Laurén, P. The two histologic main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol. Microbiol. Scand., 64: 31-49, 1965,
12. Lee, K. H., Lee, J. H., Cho, J. K., Kim, T. W., Kang, Y. K., Lee, J. S., Kim, W. K., Chung, J. G., Lee, I., and Sun, H. S. A prospective correlation of Lauren's histological classification of stomach cancer with clinicopathological findings including DNA flow cytometry. Pathol. Res. Pract., 197: 223-229, 2001.
13. Hasegawa, S., Furukawa, Y., Li, M., Satoh, S., Kato, T., Watanabe, T., Katagiri, T., Tsunoda, T., Yamaoka, Y., and Nakamura, Y. Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes. Cancer Res., 62: 7012-7017, 2002.
14. Simon, R., Radmacher, M. D., and Dobbin, K. Design of studies using DNA microarrays. Genet. Epidemiol., 23: 21-36, 2002.
15. Churchill, G. A. Fundamentals of experimental design for cDNA microarrays. Nat. Genet. 32 (Suppl.): 490-495. 2002.
16. Ming, S. C. Cellular and molecular pathology of gastric carcinoma and precursor lesions: a critical review. Gastric Cancer, 1: 31-50, 1998.
17. Rugge, M., Correa, P., Dixon, M. F., Hattori, T., Leandro, G., Lewin, K., Riddell, R. H., Sipponen, P., and Watanabe, H. Gastric dysplasia: the Padova international classification. Am. J. Surg. Pathol., 24: 167-176, 2000.
18. Jang, J., Lee, S., Jung, Y., Song, K., Fukumoto, M., Gould, V. E., and Lee, I. "Malgun (clear) Cell Change" in Helicobacter pylori gastritis reflects epithelial genomic damage and repair. Am. J. Pathol., 162: 1203-1211, 2003.
19. Dixon, M. F., Genta, R. M., Yardley, J. H., and Correa, P. Classification and grading of gastritis: the updated Sydney system. Am. J. Surg. Pathol., 20: 1161-1181, 1996.
20. Sobin, L. H., and Wittekind C. H. TNM Classification of Malignant Tumors, Ed. 5, International Union Against Cancer (UICC), pp. 59-62, New York: Wiley, 1997.
21. Maruyama, K., and Sugano, S. Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides. Gene (Amst.), 138: 171-174, 1994.
22. Kato, S., Sekine, S., Oh, S. W., Kim, N. S., Umezawa, Y., Abe, N., Yokoyama-Kobayashi, M., and Aoki, T. Construction of a human full-length cDNA bank. Gene (Amst.). 150: 243-250, 1994.
23. Tusher, V. G., Tibshirani, R., and Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA, 98: 5116-5121, 2001.
24. Tsutsui, J., Kadomatsu, K., Matsubara, S., Nakagawara, A., Hamanoue, M., Takao, S., Shimazu, H., Ohi, Y., and Muramatsu, T. A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas. Cancer Res., 53: 1281-1285, 1993.
25. Liu, J., Akoulitchev, S., Weber, A., Ge, H., Chuikov, S., Libutti, D., Wang, X. W., Conaway, J. W., Harris, C. C., Conaway, R. C., Reinberg, D., and Levens, D. Defective interplay of activators and repressors with TFIH in xeroderma pigmentosum. Cell, 104: 353-363, 2001.
26. Roymans, D., Willems, R., Van Blockstaele, D. R., and Slegers, H. Nucleoside diphosphate kinase (NDPK/NM23) and the waltz with multiple partners: possible consequences in tumor metastasis. Clin. Exp. Metastasis, 19: 465-476, 2002.
27. Yoshikawa, Y., Mukai, H., Hino, F., Asada, K., and Kato, I. Isolation of two novel genes, down-regulated in gastric cancer. Jpn. J. Cancer Res., 91: 459-463, 2000.
28. Leung, W. K., Yu, J., Chan, F. K., To, K. F., Chan, M. W., Ebert, M. P., Ng, E. K., Chung, S. C., Malfertheiner, P., and Sung, J. J. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues. J. Pathol., 197: 582-588, 2002.
29. Kirikoshi, H., and Katoh, M. Expression of TFF1, TFF2 and TFF3 in gastric cancer. Int. J. Oncol., 21: 655-659, 2002.
30. Dohchin, A., Suzuki, J. I., Seki, H., Masutani, M., Shiroto, H., and Kawakami, Y. Immunostained cathepsins B and L correlate with depth of invasion and different metastatic pathways in early stage gastric carcinoma. Cancer (Phila.), 89: 482-487, 2000.
31. Matsui, H., Kubochi, K., Shimada, A., and Hasumi, A. Desmoplastic response in scirrhous gastric carcinoma: imbalance between collagen synthesis and degradation. Anticancer Res., 20: 4733-4738, 2000.
32. Yoshikawa, T., Tsuburaya, A., Kobayashi, O., Sairenji, M., Motohashi, H., Yanoma, S., and Noguchi, Y. Intratumoral concentrations of tissue inhibitor of matrix metalloproteinase 1 in patients with gastric carcinoma a new biomarker for invasion and its impact on survival. Cancer (Phila.), 91: 1739-1744, 2001.
33. Huang, K. S., Wallner, B. P., Mattaliano, R. J., Tizard, R., Burne, C., Frey, A., Hession, C., McGray, P., Sinclair, L. K., and Chow, E. P. Two human 35 Kd inhibitors of phospholipase A2 are related to substrates of pp60v-src and of the epidermal growth factor receptor/kinase. Cell, 46: 191-199, 1986.
34. Shields, J. M., Christy, R. J., and Yang, V. W. Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest. J. Biol. Chem., 271: 20009-20017, 1996.
35. 1-S progression of the cell cycle. J. Biol. Chem., 276: 30423-30428, 2001.
36. Cmarik, J. L., Min, H., Hegamyer, G., Zhan, S., Kulesz-Martin, M., Yoshinaga, H., Matsuhashi, S., and Colburn, N. H. Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. Proc. Natl. Acad. Sci. USA, 96: 14037-14042, 1999.
37. Eklov, S., Funa, K., Nordgren, H., Olofsson, A., Kanzaki, T., Miyazono, K., and Nilsson, S. Lack of the latent transforming growth factor beta binding protein in malignant, but not benign prostatic tissue. Cancer Res., 53: 3193-3197, 1993.
38. Blobe, G. C., Schiemann, W. P., and Lodish, H. F. Role of transforming growth factor β in human disease. N. Engl. J. Med., 342: 1350-1358, 2000.
39. Brown, K. M., and Arthur, J. R. Selenium, selenoproteins and human health: a review. Public Health Nutr., 4: 593-599, 2001.
40. Calvo, A., Xiao, N., Kang, J., Best, C. J., Leiva, I., Emmert-Buck, M. R., Jorcyk, C., and Green, J. E. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors. Cancer Res., 62: 5325-5335, 2002.
41. Yu, E., Lee, H. K., Kim, H. R., Lee, M. S., and Lee, I. Acute inflammation of proliferative zone in Helicobacter pylori gastritis. Pathol. Res. Pract., 195: 689-697, 1999.
42. Tay, S. T., Leong, S. H., Yu, K., Aggarwal, A., Tan, S. Y., Lee, C. O., Wong, K., Visvanathan, J., Lim, D., Wong, W. K., Soo, K. C., Kon, O. L., and Tan, P. A combined comparative genomic hybridization and expression microarray analysis of gastric cancer reveals novel molecular subtypes. Cancer Res., 63: 3309-3316, 2003.